Summary
Boston Scientific Corporation (BSX) filed an 8-K on April 27, 2021, primarily to furnish a press release announcing their first-quarter financial results for the period ended March 31, 2021. The press release, dated April 28, 2021, provides details on the company's performance during the quarter. Investors should refer to this press release for specific financial metrics, operational highlights, and forward-looking statements, as the 8-K itself does not contain detailed financial data but rather incorporates it by reference through the furnished exhibit. The furnishing of this press release under Item 2.02 is for informational purposes and is not considered 'filed' under Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as a formally filed document. However, it serves as the primary source of Q1 2021 financial information for investors seeking to understand Boston Scientific's recent performance and outlook.
Key Highlights
- 1Boston Scientific Corporation filed an 8-K on April 27, 2021, furnishing a press release detailing its Q1 2021 financial results.
- 2The press release, dated April 28, 2021, contains the company's financial results for the quarter ended March 31, 2021.
- 3This filing serves to inform investors about the company's recent financial performance.
- 4The information is provided under Item 2.02 (Results of Operations and Financial Condition).
- 5The press release is included as Exhibit 99.1 to the 8-K filing.
- 6Information furnished under Item 2.02 is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
- 7Investors need to review Exhibit 99.1 for specific Q1 2021 financial details and commentary.